Certolizumab pegol for active Crohn's disease

Clin Gastroenterol Hepatol. 2012 Mar;10(3):327; author reply 327-8. doi: 10.1016/j.cgh.2011.10.011. Epub 2011 Oct 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Immunoglobulin Fab Fragments / administration & dosage*
  • Immunologic Factors / administration & dosage*
  • Male
  • Polyethylene Glycols / administration & dosage*

Substances

  • Immunoglobulin Fab Fragments
  • Immunologic Factors
  • Polyethylene Glycols